Market Closed -
Hong Kong S.E.
01:38:20 14/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
6.33
HKD
|
+2.10%
|
|
+0.32%
|
-11.84%
|
Fiscal Period: March |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
6,819
|
7,388
|
2,637
|
-
|
-
|
Enterprise Value (EV)
1 |
6,446
|
7,722
|
2,835
|
2,748
|
2,659
|
P/E ratio
|
-1.35
x
|
-33.4
x
|
445
x
|
32.2
x
|
21.3
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
4.2
x
|
5.01
x
|
1.47
x
|
1.26
x
|
1.07
x
|
EV / Revenue
|
3.97
x
|
5.24
x
|
1.58
x
|
1.31
x
|
1.08
x
|
EV / EBITDA
|
33.2
x
|
29.4
x
|
8.29
x
|
5.9
x
|
5.09
x
|
EV / FCF
|
-
|
-
|
7.23
x
|
11.4
x
|
9.39
x
|
FCF Yield
|
-
|
-
|
13.8%
|
8.81%
|
10.6%
|
Price to Book
|
4.36
x
|
4.57
x
|
2.06
x
|
1.94
x
|
1.73
x
|
Nbr of stocks (in thousands)
|
5,81,592
|
5,81,592
|
4,49,914
|
-
|
-
|
Reference price
2 |
11.72
|
12.70
|
5.860
|
5.860
|
5.860
|
Announcement Date
|
27/06/22
|
27/06/23
|
-
|
-
|
-
|
Fiscal Period: March |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
1,624
|
1,474
|
1,791
|
2,091
|
2,459
|
EBITDA
1 |
-
|
194.2
|
263
|
342.1
|
465.8
|
522.5
|
EBIT
1 |
-
|
-28.57
|
-190.3
|
69.2
|
178.5
|
247.7
|
Operating Margin
|
-
|
-1.76%
|
-12.91%
|
3.86%
|
8.54%
|
10.07%
|
Earnings before Tax (EBT)
1 |
-
|
-709.9
|
-217.9
|
26.81
|
157.3
|
222.3
|
Net income
1 |
-599.4
|
-701
|
-219.9
|
20.75
|
110.1
|
176.1
|
Net margin
|
-
|
-43.18%
|
-14.92%
|
1.16%
|
5.27%
|
7.16%
|
EPS
2 |
-0.3286
|
-8.700
|
-0.3800
|
0.0132
|
0.1817
|
0.2750
|
Free Cash Flow
1 |
-
|
-
|
-
|
392
|
242
|
283
|
FCF margin
|
-
|
-
|
-
|
21.88%
|
11.57%
|
11.51%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
114.59%
|
51.96%
|
54.17%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
1,889.04%
|
219.75%
|
160.72%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
24/01/22
|
27/06/22
|
27/06/23
|
-
|
-
|
-
|
Fiscal Period: March |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
334
|
199
|
112
|
21.9
|
Net Cash position
1 |
-
|
373
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
1.269
x
|
0.5804
x
|
0.2398
x
|
0.042
x
|
Free Cash Flow
1 |
-
|
-
|
-
|
392
|
242
|
283
|
ROE (net income / shareholders' equity)
|
-
|
-15%
|
-1.84%
|
2.33%
|
6.49%
|
8.9%
|
ROA (Net income/ Total Assets)
|
-
|
2.46%
|
-
|
0.3%
|
2.9%
|
-
|
Assets
1 |
-
|
-28,452
|
-
|
6,917
|
3,797
|
-
|
Book Value Per Share
2 |
-
|
2.690
|
2.780
|
2.850
|
3.020
|
3.390
|
Cash Flow per Share
2 |
-
|
2.780
|
-
|
1.370
|
0.7800
|
-
|
Capex
1 |
-
|
116
|
108
|
362
|
281
|
302
|
Capex / Sales
|
-
|
7.12%
|
7.34%
|
20.2%
|
13.43%
|
12.26%
|
Announcement Date
|
24/01/22
|
27/06/22
|
27/06/23
|
-
|
-
|
-
|
Last Close Price
5.86
CNY Average target price
8.663
CNY Spread / Average Target +47.83% Consensus |
1st Jan change
|
Capi.
|
---|
| -11.84% | 365M | | -29.11% | 70.3B | | +2.04% | 27.46B | | -6.30% | 17.8B | | +2.32% | 17.46B | | +2.10% | 15.46B | | +7.58% | 13.49B | | +10.80% | 13.06B | | +71.45% | 12.96B | | +75.00% | 12.56B |
Other Healthcare Facilities & Services
|